Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.

PubWeight™: 2.82‹?› | Rank: Top 1%

🔗 View Article (PMID 19118718)

Published in J Am Coll Cardiol on January 06, 2009

Authors

Justin A Ezekowitz1, Padma Kaul, Jeffery A Bakal, Paul W Armstrong, Robert C Welsh, Finlay A McAlister

Author Affiliations

1: Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada. justin.ezekowitz@ualberta.ca

Articles citing this

Epidemiology and risk profile of heart failure. Nat Rev Cardiol (2010) 4.88

The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol (2011) 1.39

Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ Res (2011) 1.25

Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia. J Am Heart Assoc (2013) 1.02

Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study. Am J Epidemiol (2013) 1.01

Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates. Health Serv Res (2012) 1.00

The epidemiology and management of elderly patients with myocardial infarction or heart failure. Heart Fail Rev (2010) 0.95

Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction. Circ Heart Fail (2011) 0.89

Cardiac regeneration: epicardial mediated repair. Proc Biol Sci (2015) 0.88

Heart failure in North America. Curr Cardiol Rev (2013) 0.87

Clinical effects of Xinmailong therapy in patients with chronic heart failure. Int J Med Sci (2013) 0.87

Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial Infarction. J Am Heart Assoc (2016) 0.87

STEMI and heart failure in the elderly: role of adverse remodeling. Heart Fail Rev (2010) 0.86

Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure. Curr Heart Fail Rep (2012) 0.85

Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling. Circ Cardiovasc Imaging (2016) 0.85

Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. Am Heart J (2014) 0.84

Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling. J Mol Cell Cardiol (2015) 0.84

Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction. BMC Med Genomics (2011) 0.84

Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance. Open Heart (2016) 0.83

Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective. Circ Heart Fail (2015) 0.83

Thyroid hormone and cardiac disease: from basic concepts to clinical application. J Thyroid Res (2011) 0.82

Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both. Vasc Health Risk Manag (2014) 0.81

The myriad essential roles of microRNAs in cardiovascular homeostasis and disease. Genes Dis (2014) 0.81

Trends in hospitalized acute myocardial infarction patients with heart failure in Korea at 1998 and 2008. J Korean Med Sci (2014) 0.81

Understanding palliative care on the heart failure care team: an innovative research methodology. J Pain Symptom Manage (2012) 0.80

Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project. J Am Heart Assoc (2016) 0.79

Stem cell therapy for heart disease. J Gen Intern Med (2013) 0.78

Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy. Int J Mol Med (2014) 0.77

Increasing post-myocardial infarction heart failure incidence in elderly patients a call for action. J Am Coll Cardiol (2009) 0.77

Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol (2009) 0.76

Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study design. J Arrhythm (2014) 0.76

Age-related cardiovascular disease and the beneficial effects of calorie restriction. Heart Fail Rev (2012) 0.76

Heart failure. BMJ Clin Evid (2011) 0.75

Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction. Eur Heart J Cardiovasc Pharmacother (2015) 0.75

Comparative analysis of biochemical parameters in diabetic and non-diabetic acute myocardial infarction patients. Indian Heart J (2016) 0.75

Impact of neonatal sertraline exposure on the post-myocardial infarction outcomes of adult male mice. J Cardiovasc Pharmacol (2013) 0.75

Percutaneous Ventricular Assist Devices: A Health Technology Assessment. Ont Health Technol Assess Ser (2017) 0.75

Explicit risk in acute coronary syndrome management. Can J Cardiol (2009) 0.75

Risk factors for heart failure in a cohort of patients with newly diagnosed myocardial infarction: a matched, case-control study in Iran. Epidemiol Health (2016) 0.75

STEMI care in the elderly: Does under-treatment reflect appropriate clinical judgment or therapeutic nihilism? Indian Heart J (2016) 0.75

Influence of case definition on incidence and outcome of acute coronary syndromes. Open Heart (2016) 0.75

Heart failure. BMJ Clin Evid (2010) 0.75

The effects of aging on apoptosis following myocardial infarction. Cardiovasc Ther (2013) 0.75

Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk. World J Cardiol (2017) 0.75

The derivation and validation of a simple model for predicting in-hospital mortality of acutely admitted patients to internal medicine wards. Medicine (Baltimore) (2017) 0.75

Acute mechanical circulatory support for cardiogenic shock: the "door to support" time. F1000Res (2017) 0.75

Prediction of left ventricular contractile recovery using tissue Doppler strain and strain rate measurements at rest in patients undergoing percutaneous coronary intervention. Int J Cardiovasc Imaging (2017) 0.75

Articles by these authors

Universal definition of myocardial infarction. Circulation (2007) 11.69

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Third universal definition of myocardial infarction. Circulation (2012) 8.47

Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98

Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83

Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev (2010) 6.49

Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med (2013) 6.01

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation (2007) 5.56

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ (2006) 5.03

Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ (2007) 5.02

Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med (2006) 4.90

Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA (2003) 4.88

Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med (2005) 4.85

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care (2005) 4.78

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49

Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation (2003) 4.43

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ (2007) 3.95

New evidence for stroke prevention: scientific review. JAMA (2002) 3.70

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation (2007) 3.62

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ (2006) 3.62

Accuracy of administrative databases in identifying patients with hypertension. Open Med (2007) 3.56

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56

Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med (2003) 3.43

Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25

A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med (2008) 3.21

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18

A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol (2007) 3.16

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J (2006) 3.14

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA (2007) 2.99

Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med (2014) 2.90

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA (2004) 2.89

International variation in and factors associated with hospital readmission after myocardial infarction. JAMA (2012) 2.75

Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74

Preoperative hypernatremia predicts increased perioperative morbidity and mortality. Am J Med (2013) 2.69

Neural correlates of individual ratings of emotional salience: a trial-related fMRI study. Neuroimage (2004) 2.66

Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ (2004) 2.55

Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med (2008) 2.55

Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA (2006) 2.53

Aging and the neural correlates of successful picture encoding: frontal activations compensate for decreased medial-temporal activity. J Cogn Neurosci (2005) 2.52

Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ (2005) 2.50

Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med (2009) 2.49

International differences in evolution of early discharge after acute myocardial infarction. Lancet (2004) 2.47

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation (2007) 2.42

Preoperative hyponatremia and perioperative complications. Arch Intern Med (2012) 2.42

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40

Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J (2008) 2.37

Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review. Ann Intern Med (2012) 2.35

Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med (2011) 2.34

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32

Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation (2011) 2.30

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation (2007) 2.30

Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. Arch Intern Med (2010) 2.28

Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J (2006) 2.26

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med (2002) 2.26

Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension (2008) 2.23

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet (2013) 2.22

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. JAMA (2012) 2.22

Stroke: strategies for primary prevention. Am Fam Physician (2003) 2.19

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation (2008) 2.19

Sex differences in mortality following acute coronary syndromes. JAMA (2009) 2.17

From knowledge to practice in chronic cardiovascular disease: a long and winding road. J Am Coll Cardiol (2004) 2.16

Medial frontal cortex activity and loss-related responses to errors. J Neurosci (2006) 2.15

The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension (2005) 2.15

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation (2003) 2.09

The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events. Am J Med (2002) 2.09

Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol (2005) 2.03

Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension (2011) 2.02

A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care (2005) 2.01

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2007) 2.01

Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation (2008) 1.98

Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open (2013) 1.95

Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol (2013) 1.95

Blood pressure in Canadian adults. Health Rep (2010) 1.93

Neural correlates of social and nonsocial emotions: An fMRI study. Neuroimage (2006) 1.82

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA (2009) 1.80

Better outcomes for patients treated at hospitals that participate in clinical trials. Arch Intern Med (2008) 1.77

Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens (2003) 1.76

Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail (2011) 1.75

Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry (2005) 1.75

Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial. Am Heart J (2007) 1.73

Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease. J Gen Intern Med (2002) 1.73

Evaluating research in cardiovascular medicine: citation counts are not sufficient. Circulation (2011) 1.73

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial. Circulation (2003) 1.72

Cardiology and emergency medicine: united we stand, divided we fall. Ann Emerg Med (2002) 1.72

Poverty, process of care, and outcome in acute coronary syndromes. J Am Coll Cardiol (2003) 1.71

Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure. Eur J Heart Fail (2008) 1.68